Amolyt Pharma

About

Amolyt Pharma is a clinical-stage biotechnology company developing life-changing treatments for patientssuffering from rare endocrine and metabolic diseases with a best-in-class safety profile and efficiency.Amolyt's next-gen therapeutic peptides imitate the behaviour of hormones with long-term receptor activationand possess a better physiological effect than therapies based on recombinant proteins. AZP-3601, Amolyt'slead clinical candidate, is a therapeutic peptide in development as a potential treatment forhypoparathyroidism, a rare endocrine disorder.